These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6350591)

  • 1. Proliferative responses to insulin antigens in diabetics and controls.
    Scheinin T; Groop L; Nikkilä E; Kontiainen S
    J Clin Lab Immunol; 1983 Jul; 11(3):135-41. PubMed ID: 6350591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics.
    Nell LJ; Thomas JW
    J Immunol; 1983 Aug; 131(2):701-5. PubMed ID: 6190938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The HLA system and insulin-dependent diabetes mellitus. A review and personal studies].
    Citro M; Gadaleta G; Gamba Ansaldi S; Molinatti M; Salvetti E; Bruni B
    Ann Osp Maria Vittoria Torino; 1983; 26(1-6):108-42. PubMed ID: 6388459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte proliferation as a test of the immune response to insulin in diabetics.
    Kurtz AB; Di Silvio L; Lydyard P
    Diabetes Res; 1985 Jul; 2(4):175-8. PubMed ID: 3910325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
    Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
    J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological suppressor cell activity in insulin dependent diabetes.
    Slater LM; Murray SL; Kershnar A; Mosier MA
    J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Purity and antigenicity of the new insulin preparations].
    Fankhauser S
    Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective suppressor cell generation in juvenile onset diabetes.
    Lederman MM; Ellner JJ; Rodman HM
    J Immunol; 1981 Nov; 127(5):2051-5. PubMed ID: 6457859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of C-peptide in the classification of diabetes mellitus.
    Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
    West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HL-A antigens and diabetes mellitus].
    Minev M; Khartarska S; Karalambev N; Genov Zh
    Vutr Boles; 1978; 17(6):66-71. PubMed ID: 735032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HL-A antigens in insulin-dependent diabetes mellitus].
    Mirouze J; Seignalet J; Selam JL; Lapinski H; Jaffiol C
    Nouv Presse Med; 1976 Jun; 5(26):1628-30. PubMed ID: 133329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological and immunogenetic analysis of tuberculosis and diabetes mellitus association].
    Chukanova VP; Sergeev AS; Pospelov LE; Sobkin AL
    Probl Tuberk; 2000; (4):11-4. PubMed ID: 10981422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and insulin-dependent juvenile diabetes mellitus.
    Májský A; Dvoráková L
    Czech Med; 1983; 6(3):152-8. PubMed ID: 6416792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors affecting the antigenicity of exogenous insulin in diabetics].
    Penchev II; Taneva T; Ditsov S; Andreev D
    Vutr Boles; 1985; 24(1):113-9. PubMed ID: 3895740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is diabetic microangiopathy genetically heterogeneous? HLA and diabetic nephropathy.
    Barbosa J
    Horm Metab Res Suppl; 1981; 11():77-80. PubMed ID: 6947952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.